Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.

Anionic squarticles can effectively counteract amitriptyline overdose, improving survival rates.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Trastuzumab may cause tufted hair folliculitis as a side effect.

A woman with a scalp infection and herpes recovered fully after treatment.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

Topical tofacitinib is effective and safe for treating alopecia areata.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

A man had bad reactions to a hair loss treatment called DNCB.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Teak is a durable, termite-resistant wood with medicinal benefits.

Topical tacrolimus can effectively treat erosive pustular dermatosis and related hair loss.

The FDA rejected a testosterone drug again due to safety concerns.

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

Daily subcutaneous testosterone effectively restores testosterone levels in men.